Sadeem Mahmood, MD
Cardiovascular Disease · Pine Bluff, ARNPI 1245299924
Payments from drug & device makers
Across 327 payments — averaging $39.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$3K
- Medtronic$2K
- Biotronik Inc.$2K
- Abbott$2K
- Terumo Medical Corporation$700
- Amgen$590
- plus $4K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 41 | $2,808 |
| Medtronic(2 entities) | 20 | $1,853 |
| Biotronik Inc. | 41 | $1,798 |
| Abbott | 39 | $1,618 |
| Terumo Medical Corporation | 1 | $700 |
| Amgen | 36 | $590 |
| Siemens Medical Solutions USA, Inc. | 6 | $533 |
| Johnson & Johnson | 26 | $377 |
| Merck | 18 | $339 |
| Cardiovascular Systems Inc. | 15 | $312 |
| Philips North America LLC | 11 | $297 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $198 |
| Cook Medical LLC | 2 | $191 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $186 |
| Boehringer Ingelheim | 3 | $150 |
| Boston Scientific | 6 | $137 |
| GE HealthCare | 1 | $106 |
| Shockwave Medical, Inc | 1 | $103 |
| Lexicon Pharmaceuticals, Inc. | 5 | $96 |
| Cvrx, Inc. | 1 | $91 |
| AstraZeneca | 5 | $65 |
| Sanofi-aventis U.S. LLC | 4 | $60 |
| Irhythm Technologies, Inc. | 3 | $54 |
| Amarin Pharma, Inc. | 3 | $54 |
| E.r. Squibb & Sons, L.L.C. | 3 | $51 |
| Alnylam Pharmaceuticals Inc. | 2 | $46 |
| Pfizer | 3 | $35 |
| Regeneron Healthcare Solutions, Inc. | 2 | $28 |
| Novo Nordisk | 1 | $22 |
| Abiomed | 1 | $21 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 2 | $21 |
| Biocompatibles, Inc. | 1 | $20 |
| Intact Vascular, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Bardy Diagnostics, Inc. | 1 | $15 |
| Chiesi USA, Inc. | 1 | $12 |
| Venclose Inc. | 2 | $9 |
How this compares
$13,051 in reported general payments places this provider in the 75th percentile of 130 cardiovascular disease providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Pine Bluff
- Nicholas WillisPine Bluff$15K
- Ricki FramPine Bluff$6K
- Shabbir DharamseyPine Bluff$6K
- Ian CawichLittle Rock$1.1M
- Christian Assad KottnerLittle Rock$670K
- Barry UretskyLittle Rock$609K
- Maximiliano ArroyoJonesboro$553K
- William RollefsonLittle Rock$512K
- David JonesLittle Rock$473K
- Joe HargroveLittle Rock$464K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.